http://www.mmm-online.com/legal/topic/216/ Articles tagged with Legal from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no The Swiss drug maker is defending itself against two civil fraud lawsuits filed within a week of each other. http://www.mmm-online.com/novartis-sued-for-alleged-speaker-program-abuse/article/291064/ Mon, 29 Apr 2013 20:00:47 GMT The Swiss drug maker is defending itself against two civil fraud lawsuits filed within a week of each other. MMM After a skeptical Supreme Court hearing, diagnostics and biopharma patent lawyers are sweating the outcome of Association for Molecular Pathology vs. Myriad Genetics, in which the Court could decide whether or not swatches of genes are patentable. http://www.mmm-online.com/myriad-decision-could-be-a-drag-on-personalized-medicine-rd/article/288938/ Mon, 15 Apr 2013 19:13:15 GMT After a skeptical Supreme Court hearing, diagnostics and biopharma patent lawyers are sweating the outcome of Association for Molecular Pathology vs. Myriad Genetics, in which the Court could decide whether or not swatches of genes are patentable. MMM Eight members of the Supreme Court heard testimony in the case of FTC v. Actavis this morning, and the fate of so-called "pay for delay" settlements hangs in the balance. http://www.mmm-online.com/court-could-punt-pay-for-delay-back-to-congress/article/285987/ Mon, 25 Mar 2013 20:55:10 GMT Eight members of the Supreme Court heard testimony in the case of FTC v. Actavis this morning, and the fate of so-called "pay for delay" settlements hangs in the balance. MMM Amgen "marketed the spread" between the price practices pay for Aranesp and that patients pay as a means of driving sales—to the point of having speakers tell docs that they could make a million more each year by prescribing the Amgen anemia drug over its competitor, Procrit. http://www.mmm-online.com/amgen-pleads-guilty-takes-cia-in-762-million-false-claims-act-case/article/273559/ Thu, 20 Dec 2012 19:40:46 GMT Amgen "marketed the spread" between the price practices pay for Aranesp and that patients pay as a means of driving sales—to the point of having speakers tell docs that they could make a million more each year by prescribing the Amgen anemia drug over its competitor, Procrit. MMM FDA's Jane Axelrad is leaving the Office of Regulatory Policy to head the agency's compounding policy rethink. http://www.mmm-online.com/fda-regulatory-policy-chief-to-take-on-compounding-question/article/273378/ Wed, 19 Dec 2012 21:15:27 GMT FDA's Jane Axelrad is leaving the Office of Regulatory Policy to head the agency's compounding policy rethink. MMM A federal appeals court has overturned the conviction of a drug rep for detailing a drug off-label on First Amendment grounds, ordering the lower court to retry the case. http://www.mmm-online.com/court-says-off-label-decision-against-jazz-rep-ran-afoul-of-free-speech-protections/article/270987/ Mon, 03 Dec 2012 21:37:39 GMT A federal appeals court has overturned the conviction of a drug rep for detailing a drug off-label on First Amendment grounds, ordering the lower court to retry the case. MMM Forest Labs may have settled a patent challenge from generics maker Hetero, but the drugmaker has yet to come to terms with six others. http://www.mmm-online.com/for-forest-one-bystolic-test-down-six-to-go/article/265875/ Mon, 29 Oct 2012 17:10:29 GMT Forest Labs may have settled a patent challenge from generics maker Hetero, but the drugmaker has yet to come to terms with six others. MMM Pharma's med/legal/regulatory (MLR) teams, managers of risk and so often the scapegoats for creating roadblocks to digital innovation, were discussed in a much friendlier light by digital marketers at last week's ExL Digital Pharma East conference in Philadelphia. http://www.mmm-online.com/pharma-execs-mlr-teams-are-friendlier-on-digital/article/264723/ Mon, 22 Oct 2012 19:31:23 GMT Pharma's med/legal/regulatory (MLR) teams, managers of risk and so often the scapegoats for creating roadblocks to digital innovation, were discussed in a much friendlier light by digital marketers at last week's ExL Digital Pharma East conference in Philadelphia. MMM Hologic alleges KV has botched the marketing and wants rights to the drug. KV disagrees. http://www.mmm-online.com/hologic-seeking-rights-to-makena-trades-barbs-with-kv/article/260518/ Mon, 24 Sep 2012 19:00:33 GMT Hologic alleges KV has botched the marketing and wants rights to the drug. KV disagrees. MMM US District Court Judge Andrew Guilford slammed the breaks on Merz's foray into a market dominated by Botox, siding with Allergan in a case about stealing intellectual property and poaching sales reps. http://www.mmm-online.com/judge-puts-freeze-on-merz-bid-to-challenge-botox/article/231078/ Wed, 07 Mar 2012 20:20:52 GMT US District Court Judge Andrew Guilford slammed the breaks on Merz's foray into a market dominated by Botox, siding with Allergan in a case about stealing intellectual property and poaching sales reps. MMM